Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract …
Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing. News and analysis on clinical trial services and contract research and development. Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist. Wegovy manufacturer Ascendis Pharma has been tasked with supporting the ...
Recipharm bolsters global production facilities
Oct 8, 2024 · Small molecules in focus as Recipharm bolsters global production facilities. Months after divesting seven European sites, the Swedish contract development and manufacturing organisation (CDMO) Recipharm is expanding its manufacturing capacity with undisclosed investments in its small molecule offerings. One of Recipharm’s main aims is the ...
Extractables and leachables analysis of pharmaceutical products
Feb 29, 2024 · The FDA defines extractables and leachables as follows: 2 . Extractables: Organic and inorganic chemical species that can be released from the surfaces of components used in the manufacture and storage of drug products under laboratory conditions (accelerated or exaggerated temperatures, solvents or surface exposure).
Powered by Ingredients + Innovation
This innovative prototype kit features six starting formulations for oral solid dose, oral liquid dose, and topical applications. Each unique formulation was specifically designed to enhance your line of pharmaceutical products across a variety of dosage forms including tablets, capsules, chewable tablets, powders, gels, and topicals.
Interview: Adragos Pharma and the evolving world of outsourcing
Oct 4, 2024 · Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of pharmaceutical outsourcing. We also delve into the latest trends, the rise of AI and the increasing focus on sustainability. How has the role of contract development and manufacturing organizations (CDMOs) evolved over the ...
uMotif acquires ClinOne, integrates eConsent for clinical trials
Sep 17, 2024 · uMotif expands site and patient platform with ClinOne acquisition. uMotif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its platform with the acquisition of ClinOne, a provider of site platform solutions. Announced on September 4, 2024, this acquisition positions uMotif to enhance ...
GSK's £200 million investment in the UK and $1.1 billion acquisition
Jan 16, 2024 · GSK to pump £200 million into UK to boost medicine production and buys Aiolos Bio for $1.1 billion. Pharma giant, GSK, plans to invest £200 million ($253 million) into the UK over the next two years and has acquired Aiolos Bio for $1.1 billion (£870 million). The company formerly known as Glaxosmithkline will put the money towards its sites ...
Symbiosis unveils expanded facility at CPHI Milan 2024
Oct 2, 2024 · Symbiosis expands sterile manufacturing with new facility and innovations. As CPHI Milan 2024 approaches, Symbiosis Pharmaceutical Services is gearing up to showcase major expansions and innovations in sterile biopharmaceutical manufacturing. The event provides a great platform for the company to present its newest addition—a 20,000 sq ft ...
The impact of AI technology in pharmacovigilance
Oct 1, 2024 · Once identified, the AI can automatically escalate that conversation to a patient safety or pharmacovigilance team. All in all, AI helps eliminate unnecessary, initial manual note taking by an agent in between calls by a factor of 10-15 minutes per interaction, decreases the number of “false alarms” escalated for review, and expedites the ...
CPHI Milan 2024: Enzene targets cost savings and efficiency
Oct 2, 2024 · Large reduction in COGS: By 2025, EnzeneX 2.0 expects to produce 40 kg/1000 L batches at $40/gram, redefining FCCM economics. Lower operational costs and higher productivity can lead to up to 50% reductions in overall cost per gram. Higher Titer Clones: EnzeneX 2.0 maximizes protein yield per cell line with superior productivity.